To see the other types of publications on this topic, follow the link: Covid long.

Journal articles on the topic 'Covid long'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Covid long.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kuznecova, Sof'ya, and Elena Belyaeva. "LONG COVID SYNDROME." Clinical Medicine and Pharmacology 9, no. 1 (2023): 31–32. http://dx.doi.org/10.12737/2409-3750-2023-9-1-31-32.

Full text
Abstract:
Clinical observations of polymorbid patients with Long Covid syndrome in real clinical practice are presented. Treatment options for patients with lung, muscle, cardiovascular and nervous system damage, immuno-inflammatory syndrome are proposed.
APA, Harvard, Vancouver, ISO, and other styles
2

Aline, Miranda dos Santos Lima. "COVID LONGA: REVISÃO BIBLIOGRAFICA DAS REPERCUSÕES CARDIOPULMONARES." Revistaft 28, no. 136 (2024): 15. https://doi.org/10.5281/zenodo.12750115.

Full text
Abstract:
Introdução: A COVID-19, teve o primeiro registro em dezembro de 2019 na China e em outubro de 2021 a OMS reconheceu como doença a COVID longa. Um estudo desenvolvido pela Fiocruz, mostra que 50% das pessoas apresentam sintomas pós-infecção em seguida do diagnóstico. Populações com doenças preexistentes como: hipertensão arterial crônica, diabetes, cardiopatias, câncer, doenças pulmonares, doenças renais, tabagismo, além de serem fatores de risco para a contaminação do v&i
APA, Harvard, Vancouver, ISO, and other styles
3

Mihajlović, Miroslav, Bogdan Marković, Milan Marinković, Nebojša Mujović, and Tatjana Potpara. "Long COVID-19 syndrome: An overview." Medicinski podmladak 74, no. 4 (2023): 26–34. http://dx.doi.org/10.5937/mp74-47797.

Full text
Abstract:
The Long COVID-19 syndrome has emerged as global epidemic, affecting individuals after an acute infection caused by the Severe acute respiratory syndrome coronavirus 2, impacting multiple organs, including the heart. The most common symptoms encompass fatigue and shortness of breath, which could persist for months after an acute COVID-19 infection. Numerous studies have researched the pathophysiology of Long COVID-19 syndrome, suggesting that local tissue damage and hyperinflation could be employed as possible mechanisms of Long COVID-19 syndrome. Many blood biomarkers (blood urea nitrogen, D-
APA, Harvard, Vancouver, ISO, and other styles
4

TICĂRĂU, Adriana, Mihaela Adela IANCU, and Dumitru MATEI. "Long COVID syndrome – general aspects." Romanian Journal of Medical Practice 16, no. 2 (2021): 174–77. http://dx.doi.org/10.37897/rjmp.2021.2.12.

Full text
Abstract:
2020), growing scientific evidence worldwide suggests that a small percentage of people who have developed COVID-19 and healed after the initial infection may experience a series of persistent symptoms over a period of more than 12 weeks, such as marked fatigue, shortness of breath, confusion, diarrhea, or other symptoms that cannot be explained by an alternative diagnosis. This status has been called “long COVID syndrome” or ”post COVID syndrome”.
APA, Harvard, Vancouver, ISO, and other styles
5

Editor in Chief, The. "Long COVID." BIRDEM Medical Journal 11, no. 2 (2021): 80–83. http://dx.doi.org/10.3329/birdem.v11i2.53126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Visan, Ioana. "Long COVID." Nature Immunology 22, no. 8 (2021): 934–35. http://dx.doi.org/10.1038/s41590-021-00992-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hofman, Eline. "LONG COVID." TvPO 17, no. 1 (2022): 20–22. http://dx.doi.org/10.1007/s12503-022-0927-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Masood, Mohammed, Sai Sundeep Chodisetti, and Ahmed S. BaHammam. "Long COVID." Journal of Nature and Science of Medicine 6, no. 1 (2023): 3–11. http://dx.doi.org/10.4103/jnsm.jnsm_133_22.

Full text
Abstract:
The new devastating pandemic coronavirus disease 2019 (COVID-19) caused by the novel coronavirus severe acute respiratory syndrome (SARS-CoV-2) has been related to approximately 600 million cases and more than six million deaths till now. After recovery from COVID-19, some patients develop long-term sequelae called long COVID (LC). LC cases have been reported with multi-system involvement, with the most common being neuro-psychiatric, cardiorespiratory, hematological, and gastrointestinal systems highlighting the need for multidisciplinary team involvement and treatment. Since we are more than
APA, Harvard, Vancouver, ISO, and other styles
9

S. N., Puzin, Potapov V. N., Bogova O. T., and Velikolug K. A. "MEDICAL REHABILITATION FOR LONG-COVID INFECTION." Bulletin of the Russian association of specialists in medical and social expert evaluation, rehabilitation and rehabilitation industry 4 (2023): 69–86. http://dx.doi.org/10.17238/issn1999-2351.2023.4.69-86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Belotserkovskaya, Yulia G., Anna G. Romanovskikh, Igor P. Smirnov, and Alexander I. Sinopalnikov. "Long COVID-19." Consilium Medicum 23, no. 3 (2021): 261–68. http://dx.doi.org/10.26442/20751753.2021.3.200805.

Full text
Abstract:
The term “long COVID-19” describes the long-term effects of the novel coronavirus infection COVID-19. Patients with severe COVID-19 who require hospitalization, as well as those who are on outpatient treatment with mild clinical forms of the disease, often report persistent fatigue, shortness of breath, pain, cough and other respiratory and extrapulmonary symptoms for weeks and months. The generally accepted time frame that separates the duration of the acute and subacute phase of infection from the long COVID-19 is 28 days. The article describes the duration and the course of clinical disorde
APA, Harvard, Vancouver, ISO, and other styles
11

Di Toro, Alessandro, Antonio Bozzani, Guido Tavazzi, et al. "Long COVID: long-term effects?" European Heart Journal Supplements 23, Supplement_E (2021): E1—E5. http://dx.doi.org/10.1093/eurheartj/suab080.

Full text
Abstract:
Abstract The term Long COVID (or Post COVID) describes a condition characterized by persistence of symptoms for at least 12 weeks after the onset of COVID-19. It may last several months but the duration is still matter of observation. The symptoms and the clinical manifestations are clinically heterogeneous and suggesting involvement of multi-organs/systems, including the cardiovascular system. The general recurrent symptoms include fatigue, breathlessness, myalgia, headache, loss of memory, and impaired concentration. Patients report loss of their previous psychophysical performance. Cardiova
APA, Harvard, Vancouver, ISO, and other styles
12

Martelletti, Paolo, E. Bentivegna, V. Spuntarelli, and M. Luciani. "Long-COVID Headache." SN Comprehensive Clinical Medicine 3, no. 8 (2021): 1704–6. http://dx.doi.org/10.1007/s42399-021-00964-7.

Full text
Abstract:
AbstractThe so-called long COVID-19 is a set of symptoms that accompanies the patient even for months after discharge from the hospital. These symptoms include easy muscle fatigue, moderate breathlessness, persistent headache, the feeling of a foggy head, and the development of psychiatric disorders. In general, the quality of life of at least half of the patients who come out of the COVID-19 syndrome, both mild and severe, shows a markedly worsening despite having passed a difficult physical and psychological test. Among all the neurological disorders that can most frequently be found in the
APA, Harvard, Vancouver, ISO, and other styles
13

Simoneaux, Richard, and Steven L. Shafer. "Long COVID Revisited." ASA Monitor 86, no. 6 (2022): 1–5. http://dx.doi.org/10.1097/01.asm.0000833688.97991.37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Taribagil, Priyal, Dean Creer, and Hasan Tahir. "‘Long COVID’ syndrome." BMJ Case Reports 14, no. 4 (2021): e241485. http://dx.doi.org/10.1136/bcr-2020-241485.

Full text
Abstract:
SARS-CoV-2 has resulted in a global pandemic and an unprecedented public health crisis. Recent literature suggests the emergence of a novel syndrome known as ‘long COVID’, a term used to describe a diverse set of symptoms that persist after a minimum of 4 weeks from the onset of a diagnosed COVID-19 infection. Common symptoms include persistent breathlessness, fatigue and cough. Other symptoms reported include chest pain, palpitations, neurological and cognitive deficits, rashes, and gastrointestinal dysfunction. We present a complex case of a previously well 28-year-old woman who was diagnose
APA, Harvard, Vancouver, ISO, and other styles
15

Tammaro, Antonella, Francesca Romana Parisella, and Ganiyat Adenike Ralitsa Adebanjo. "Cutaneous long COVID." Journal of Cosmetic Dermatology 20, no. 8 (2021): 2378–79. http://dx.doi.org/10.1111/jocd.14291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Murray, Terry. "Unpacking “long COVID”." Canadian Medical Association Journal 193, no. 9 (2021): E318—E319. http://dx.doi.org/10.1503/cmaj.1095923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Naeije, Robert, and Sergio Caravita. "Phenotyping long COVID." European Respiratory Journal 58, no. 2 (2021): 2101763. http://dx.doi.org/10.1183/13993003.01763-2021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Gerloff, Christian. "Long-COVID-19." InFo Neurologie + Psychiatrie 24, no. 1 (2022): 3. http://dx.doi.org/10.1007/s15005-021-2215-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Southard, Erik P. "Navigating Long COVID." American Nurse Journal 20, no. 01 (2025): 06–13. https://doi.org/10.51256/anj012506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Schwarz, Stefan, and Veith Hümmert. "Pediatric Long COVID." Science Insights 45, no. 3 (2024): 1507–14. http://dx.doi.org/10.15354/si.24.re1051.

Full text
Abstract:
The emergence of long COVID, a condition characterized by persistent symptoms lasting beyond the acute phase of COVID-19 infection, has raised concerns about its impact on pediatric populations. While initially thought to affect primarily adults, increasing reports suggest that children can also experience prolonged symptoms post-COVID-19. Understanding the unique aspects of pediatric long COVID, including its symptoms, diagnosis, and management, is crucial for healthcare providers and families navigating the long-term effects of the pandemic on children’s health. This article provides an over
APA, Harvard, Vancouver, ISO, and other styles
21

Nath, Avindra. "Long-Haul COVID." Neurology 95, no. 13 (2020): 559–60. http://dx.doi.org/10.1212/wnl.0000000000010640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Kovac, Adam. "Long COVID Update." Brain & Life 18, no. 6 (2022): 28–32. http://dx.doi.org/10.1097/01.nnn.0000904776.13569.ed.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Spyropoulos M.S, Vasileios, Agathi Spiropoulou M.S, Georgia Spyropoulou, Dimosthenis Lykouras, Kiriakos Karkoulias, and Kostas Spiropoulos. "Long Covid-19." Archives of Pulmonology and Respiratory Medicine 4, no. 1 (2021): 16–20. http://dx.doi.org/10.22259/2639-362x.0401004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Digeronimo, Sharyn. "Long COVID Responses." Brain & Life 19, no. 1 (2023): 4. http://dx.doi.org/10.1097/01.nnn.0000920128.62160.41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ehrlich, Melanie. "Long COVID Responses." Brain & Life 19, no. 1 (2023): 4. http://dx.doi.org/10.1097/01.nnn.0000920132.41294.08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

O’Donnell, Allison N. "Contextualizing Long COVID." American Journal of Health Promotion 39, no. 6 (2025): 951–53. https://doi.org/10.1177/08901171241308066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Roth, Alan, Pan San Chan, and Wayne Jonas. "Addressing the Long COVID Crisis: Integrative Health and Long COVID." Global Advances in Health and Medicine 10 (January 2021): 216495612110565. http://dx.doi.org/10.1177/21649561211056597.

Full text
Abstract:
While COVID-19 has killed millions of people globally, its lasting effects on the health and well-being of entire populations are just becoming clear. As many as 30% of those diagnosed with COVID-19 report continuing health-related problems, regardless of the severity of the initial infection. Given the infection rate in the world, that translates to between 5.4 and 17.9 million globally; about 700 000 in the US. The syndrome goes by many names; here we call it “long COVID.” Patients experience a wide range of symptoms, including serious organ system effects such as pulmonary fibrosis, myocard
APA, Harvard, Vancouver, ISO, and other styles
28

Pellino, Stefania, Margherita Luciano, Rosamaria Luciano, et al. "Long-COVID-19 Symptoms after Infection in COVID Long-Haulers." Open Journal of Epidemiology 11, no. 04 (2021): 473–82. http://dx.doi.org/10.4236/ojepi.2021.114038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Wagner, Hans-Otto. "Hausärztliche Handlungsempfehlung: Post-Covid/Long-Covid." Zeitschrift für Komplementärmedizin 14, no. 02 (2022): 20–23. http://dx.doi.org/10.1055/a-1840-8654.

Full text
Abstract:
SummaryDie Coronavirus-Krankheit 2019 (Covid-19) wird oft als Multiorgan-Krankheit mit einem breiten Spektrum von Manifestationen angesehen. Ähnlich wie bei anderen Infektionskrankheiten kann Covid-19 für einen Teil der Erkrankten längerfristige Auswirkungen auf die Lebensqualität haben. Dieser Beitrag stellt die relevanten hausärztlichen Handlungsempfehlungen aus der S1-Leitlinie vor (AWMF-Register Nr. 020/027 Version 1–07/2021, [1]). Die Therapie orientiert sich an den Symptomen. Für eine spezifische Therapie gibt es bislang noch keine wissenschaftlich belastbaren Belege. Therapieziele sollt
APA, Harvard, Vancouver, ISO, and other styles
30

Gupta, Sashi B., M. Subramanyam, S. Preeti, Suganya PP Krishna Pillai, Garapati N. Sowmya, and M. Chandrashekar. "Post-COVID–Long COVID—What More?" Indian Journal of Private Psychiatry 16, no. 2 (2022): 85–86. http://dx.doi.org/10.5005//jp-journals-10067-0114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Gupta, Sashi B., M. Subramanyam, S. Preeti, Suganya PP Krishna Pillai, Garapati N. Sowmya, and M. Chandrashekar. "Post-COVID–Long COVID—What More?" Indian Journal of Private Psychiatry 16, no. 2 (2022): 85–86. http://dx.doi.org/10.5005/jp-journals-10067-0114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Köllner, Volker. "S1-Leitlinie »Post-COVID / Long-COVID«." Ärztliche Psychotherapie 16, no. 4 (2021): 264–66. http://dx.doi.org/10.21706/aep-16-4-264.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Wagner, Hans-Otto. "Hausärztliche Handlungsempfehlung: Post-COVID/Long-COVID." Allgemeinmedizin up2date 02, no. 04 (2021): 302–6. http://dx.doi.org/10.1055/a-1550-6717.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Koczulla, A. R., T. Ankermann, U. Behrends, et al. "S1-Leitlinie „Post-COVID/Long-COVID“." Der Chirurg 93, no. 1 (2022): 101–2. http://dx.doi.org/10.1007/s00104-021-01543-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Hugon, Jacques. "COVID 19 : COVID long et neurologie." Revue Neurologique 178 (April 2022): S160—S161. http://dx.doi.org/10.1016/j.neurol.2022.02.056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Köllner, Volker. "S1-Leitlinie »Post-COVID / Long-COVID«." Ärztliche Psychotherapie 18, no. 1 (2023): 65–67. http://dx.doi.org/10.21706/aep-18-1-65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Schütz, Burkhard, and Meike Crecelius. "Long-COVID und Post-COVID-Syndrom." Zeitschrift für Orthomolekulare Medizin 21, no. 01 (2023): 8–12. http://dx.doi.org/10.1055/a-2009-3541.

Full text
Abstract:
ZusammenfassungUnter dem Post-COVID-Syndrom (PCS) versteht man eine länger als 12 Wochen anhaltende Symptomatik mit Fatigue, Kurzatmigkeit, eingeschränkter Leistungsfähigkeit u. a., die bei rund 15% der Patienten nach einer akuten Infektion mit SARS-CoV-2 auftritt. Als Ursache werden Veränderungen im Mikrobiom und Störungen des Tryptophanstoffwechsels diskutiert, welche zu einer vermehrten Umwandlung von Tryptophan in prooxidativ und proinflammatorisch wirkende Abbauprodukte führen. Nach aktuellen Studien können infolge der Infektion latente Viren wie Epstein-Barr-, Cytomegalie- und Varizella-
APA, Harvard, Vancouver, ISO, and other styles
38

Singh, Carter. "Long COVID: playing the long game." British Journal of General Practice 71, no. 712 (2021): 507. http://dx.doi.org/10.3399/bjgp21x717521.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Makoni, Munyaradzi. "A long journey to long COVID." Lancet Respiratory Medicine 11, no. 1 (2023): 21–22. http://dx.doi.org/10.1016/s2213-2600(22)00499-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Conard, Scott, Mark Cunningham-Hill, Mohannad Kusti, Suresh Mukherji, Wayne Rawlins, and Stan Schwartz. "Employers’ Long Game for Long Covid." American Journal of Health Promotion 39, no. 6 (2025): 965–68. https://doi.org/10.1177/08901171241308066c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Venkata Abhinav, Atluri, Rajeswari Sankaralingam, Sudagar Singh, Divya Yanamadala, and Nidhi Prabhu. "An Interesting Case of Long Covid Vasculitis." International Journal of Science and Research (IJSR) 14, no. 5 (2025): 431–34. https://doi.org/10.21275/sr25506095237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Sivyakova, Olga N., Elena S. Skripkina, and Olga V. Voronova. "A clinical case of multiple predictors long-COVID-19." Clinical review for general practice 3, no. 5 (2022): 23–26. http://dx.doi.org/10.47407/kr2022.3.5.00159.

Full text
Abstract:
The aim is to demonstrate the case of multiple predictors of long-COVID-19, to try to explain the data of laboratory and instrumental research methods, the failure of antiarrhythmic therapy. Features of the clinical case: an elderly patient was not vaccinated against COVID-19, suffered from hypertension and obesity for a long time, was hospitalized with COVID-19, complicated by community-acquired pneumonia of moderate severity. Subsequently, atrial fibrillation developed, which could not be eliminated. Long-COVID risk factors: female gender, polymorbid background, elevated C-reactive protein l
APA, Harvard, Vancouver, ISO, and other styles
43

Voliansky, Andrii, Maiia Smilianska, and Tetiana Didorenko. "Algorithm for predicting the risk of developing long-Covid in patients with Covid-19." Annals of Mechnikov Institute, no. 3 (September 7, 2023): 81–82. https://doi.org/10.5281/zenodo.8324965.

Full text
Abstract:
A model for predicting the risk of developing Long-covid in patients with Covid-19 is proposed for implementation in the practice of family doctors, pediatricians, therapists, clinical immunologists, and allergists. The essence of the implementation: creation of a model for predicting the risk of developing Long-covid by ranking the leading clinical and laboratory indicators, with the determination of their diagnostic informativeness and scoring, followed by the sum of the points inherent in the patient at the time of calculation.
APA, Harvard, Vancouver, ISO, and other styles
44

Sarıoğlu, Nurhan, Gülden Deniz Aksu, Hikmet Çoban, et al. "Clinical and radiological outcomes of long-COVID: Is the post-COVID fibrosis common?" Tuberk Toraks 71, no. 1 (2023): 48–57. http://dx.doi.org/10.5578/tt.20239907.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Lutchmansingh, Denyse D., Jean Paul Higuero Sevilla, Jennifer D. Possick, and Mridu Gulati. "“Long Haulers”." Seminars in Respiratory and Critical Care Medicine 44, no. 01 (2023): 130–42. http://dx.doi.org/10.1055/s-0042-1759568.

Full text
Abstract:
AbstractPost-COVID conditions continue to afflict patients long after acute severe acute respiratory syndrome-coronavirus-2 (SARS CoV-2) infection. Over 50 symptoms across multiple organ systems have been reported, with pulmonary, cardiovascular, and neuropsychiatric sequelae occurring most frequently. Multiple terms have been used to describe post-COVID conditions including long COVID, long-haul COVID, postacute coronavirus disease 2019 (COVID-19), postacute sequelae of SARS-CoV-2 infection, long-term effects of COVID, and chronic COVID-19; however, standardized assessments and treatment algo
APA, Harvard, Vancouver, ISO, and other styles
46

O’Keefe, Louise C. "Post-Acute COVID 19 Syndrome, ‘Long COVID’." Workplace Health & Safety 71, no. 5 (2023): 263. http://dx.doi.org/10.1177/21650799231164605.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Bopp, Katrin, and Andrea Meienberg. "Medikamentöse Behandlung von Long-COVID/Post-COVID." Revue Médicale Suisse 20, no. 858 (2024): 178–79. http://dx.doi.org/10.53738/revmed.2024.20.858.178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Gioeva, Z. V., A. S. Kontorschikov, E. O. Zentsova, et al. "CLINICAL AND MORPHOLOGICAL FEATURES OF INTERNAL ORGANS FOR CHRONIC COVID-19 (LONG-COVID)." Современные проблемы науки и образования (Modern Problems of Science and Education), no. 6 2024 (2024): 32. https://doi.org/10.17513/spno.33788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Sivan, Manoj, Darren Charles C. Greenwood, and Tracey Smith. "Long covid as a long term condition." BMJ Medicine 4, no. 1 (2025): e001366. https://doi.org/10.1136/bmjmed-2025-001366.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

PATIL, SARANG. "LONG COVID: A LONG RACE TO WIN." CHEST 164, no. 4 (2023): A5822—A5823. http://dx.doi.org/10.1016/j.chest.2023.07.3754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!